Personalis Dirección
Dirección controles de criterios 2/4
El CEO de Personalis es Chris Hall , nombrado en Dec 2022, tiene una permanencia de 1.92 años. compensación anual total es $1.73M, compuesta por 30.9% salario y 69.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.25% de las acciones de la empresa, por valor de $618.00K. La antigüedad media del equipo directivo y de la junta directiva es de 3.3 años y 2.5 años, respectivamente.
Información clave
Chris Hall
Chief Executive Officer (CEO)
US$1.7m
Compensación total
| Porcentaje del salario del CEO | 30.9% |
| Permanencia del CEO | 1.9yrs |
| Participación del CEO | 0.3% |
| Permanencia media de la dirección | 3.3yrs |
| Promedio de permanencia en la Junta Directiva | 2.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Personalis, Inc. (NASDAQ:PSNL) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 19
The Proper Play On Personalis
Oct 28Investors Still Aren't Entirely Convinced By Personalis, Inc.'s (NASDAQ:PSNL) Revenues Despite 28% Price Jump
Sep 14A Piece Of The Puzzle Missing From Personalis, Inc.'s (NASDAQ:PSNL) 131% Share Price Climb
Jul 25Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower
Apr 19Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story
Mar 02Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story
Dec 18Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?
Dec 04Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely
Sep 04Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)
Apr 17The Prognosis For Personalis
Jun 16Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?
Jun 09Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?
Feb 17Personalis: Getting Personal Again
Feb 02Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$91m |
| Jun 30 2024 | n/a | n/a | -US$81m |
| Mar 31 2024 | n/a | n/a | -US$93m |
| Dec 31 2023 | US$2m | US$534k | -US$108m |
| Sep 30 2023 | n/a | n/a | -US$113m |
| Jun 30 2023 | n/a | n/a | -US$110m |
| Mar 31 2023 | n/a | n/a | -US$114m |
| Dec 31 2022 | US$2m | US$83k | -US$113m |
Compensación vs. Mercado: La compensación total ($USD1.73M) de Chris está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD1.48M).
Compensación vs. Ingresos: La compensación de Chris ha aumentado mientras la empresa no es rentable.
CEO
Chris Hall (55 yo)
1.9yrs
Permanencia
US$1,726,790
Compensación
Mr. Christopher M. Hall, also known as Chris, served as Senior Vice President and Head of Diagnostics Business at Personalis, Inc. since October 2022 until December 31, 2022 and serves as its President sin...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 1.9yrs | US$1.73m | 0.25% $ 618.0k | |
| CFO & COO | 5.7yrs | US$1.67m | 0.22% $ 540.0k | |
| Senior VP & Chief Legal Officer | 4.6yrs | US$674.28k | 0.095% $ 233.8k | |
| Executive VP of R&D and Chief Medical Officer | 3.3yrs | US$1.28m | 0.16% $ 383.0k | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | sin datos | sin datos | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | sin datos | sin datos | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | sin datos | sin datos | |
| Vice President of Worldwide Sales | 11.6yrs | sin datos | sin datos | |
| Senior Vice President of Genomic Laboratory Operations | 3.2yrs | sin datos | sin datos | |
| Senior Vice President of Business Development | 1.8yrs | sin datos | sin datos | |
| Senior Vice President of Regulatory | 1.1yrs | sin datos | sin datos |
3.3yrs
Permanencia media
53yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de PSNL se considera experimentado (3.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 1.7yrs | US$1.73m | 0.25% $ 618.0k | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | sin datos | sin datos | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | sin datos | sin datos | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 1.4yrs | US$154.00k | sin datos | |
| Independent Chair of the Board | 5.2yrs | US$173.05k | 0.019% $ 46.9k | |
| Independent Director | 5.5yrs | US$121.38k | 0.019% $ 46.9k | |
| Independent Director | 3.7yrs | US$108.88k | 0.037% $ 90.6k | |
| Advisor to the Board | 1.9yrs | US$5.62m | sin datos | |
| Independent Director | 2.3yrs | US$103.88k | 0.015% $ 35.8k | |
| Independent Director | 2.7yrs | US$116.38k | 0.025% $ 61.1k |
2.5yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de PSNL no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.